Neurocrine Bio. (NBIX) PT Lowered to $188 at UBS
Tweet Send to a Friend
UBS analyst Ashwani Verma lowered the price target on Neurocrine Bio. (NASDAQ: NBIX) to $188.00 (from $195.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
